Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2002 6
2003 6
2004 1
2005 6
2006 5
2007 5
2008 1
2009 3
2010 2
2011 6
2012 9
2013 6
2014 7
2015 10
2016 9
2017 6
2018 3
2019 6
2020 9
2021 9
2022 10
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Nutritional modulation of inflammation and insulin resistance.
Hirabara SM, Gorjao R, Curi R, Leandro CG, Marzuca-Nassr GN. Hirabara SM, et al. Among authors: leandro cg. Front Nutr. 2023 Mar 23;10:1181809. doi: 10.3389/fnut.2023.1181809. eCollection 2023. Front Nutr. 2023. PMID: 37032773 Free PMC article. No abstract available.
Covid-19 and Exercise-Induced Immunomodulation.
Leandro CG, Ferreira E Silva WT, Lima-Silva AE. Leandro CG, et al. Neuroimmunomodulation. 2020;27(1):75-78. doi: 10.1159/000508951. Epub 2020 Jun 5. Neuroimmunomodulation. 2020. PMID: 32506067 Free PMC article. No abstract available.
Mycobacterial efflux pumps and chemotherapeutic implications.
Viveiros M, Leandro C, Amaral L. Viveiros M, et al. Among authors: leandro c. Int J Antimicrob Agents. 2003 Sep;22(3):274-8. doi: 10.1016/s0924-8579(03)00208-5. Int J Antimicrob Agents. 2003. PMID: 13678834 Review.
Leishmaniasis: efflux pumps and chemoresistance.
Leandro C, Campino L. Leandro C, et al. Int J Antimicrob Agents. 2003 Sep;22(3):352-7. doi: 10.1016/s0924-8579(03)00211-5. Int J Antimicrob Agents. 2003. PMID: 13678842 Review.
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19.
Izadi Z, Brenner EJ, Mahil SK, Dand N, Yiu ZZN, Yates M, Ungaro RC, Zhang X, Agrawal M, Colombel JF, Gianfrancesco MA, Hyrich KL, Strangfeld A, Carmona L, Mateus EF, Lawson-Tovey S, Klingberg E, Cuomo G, Caprioli M, Cruz-Machado AR, Mazeda Pereira AC, Hasseli R, Pfeil A, Lorenz HM, Hoyer BF, Trupin L, Rush S, Katz P, Schmajuk G, Jacobsohn L, Seet AM, Al Emadi S, Wise L, Gilbert EL, Duarte-García A, Valenzuela-Almada MO, Isnardi CA, Quintana R, Soriano ER, Hsu TY, D'Silva KM, Sparks JA, Patel NJ, Xavier RM, Marques CDL, Kakehasi AM, Flipo RM, Claudepierre P, Cantagrel A, Goupille P, Wallace ZS, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Robinson PC, Machado PM, Griffiths CEM, Barker JN, Smith CH, Yazdany J, Kappelman MD; Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of COVID-19 Infection (PsoProtect); the Secure Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD); and the COVID-19 Global Rheumatology Allianc; Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of COVID-19 Infection (PsoProtect); the Secure Epidemiology of Coronavirus Under Research Exclusion for Inflammat… See abstract for full author list ➔ Izadi Z, et al. JAMA Netw Open. 2021 Oct 1;4(10):e2129639. doi: 10.1001/jamanetworkopen.2021.29639. JAMA Netw Open. 2021. PMID: 34661663 Free PMC article.
116 results